Tvardi Therapeutics, Inc.
TVRD
$1.07+7.00%
End of day · as of Oct 16, 2026, 2:01 AM ET
Mkt cap
$10.04M
EV/Sales
-1.50
P/E ratio
N/A
FY2024 Revenue
$7.14M
EPS (H1 2026)
$-1.41
Gross Margin (FY2024)
N/A
Profit Margin (FY2024)
-992.95%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Tvardi Therapeutics, Inc. (TVRD) is a biotechnology company listed on US.
Latest reported TVRD revenue for 2024-12-31 was $7.1M. Net income was -$70.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. TVRD currently screens at market cap $10.0M.
Use this TVRD research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full TVRD income, balance, and cash tables.
Tvardi Therapeutics, Inc. (TVRD) is a biotechnology company in the Healthcare sector.
Latest cached Tvardi Therapeutics, Inc. (TVRD) revenue for Dec 31, 2024 was $7.1M. Net income was -$70.9M. Statements: https://lician.com/financials/tvrd
Tvardi Therapeutics, Inc. (TVRD) market capitalization is $10.0M on the latest cached snapshot.
Tvardi Therapeutics, Inc. (TVRD) cached previous close $1.00; day range $1.03 – $1.07; volume 93,078. Session quote: https://lician.com/quote/tvrd
Tvardi Therapeutics, Inc. (TVRD) latest cached earnings event is "TVRD earnings" on Aug 14, 2026. Earnings calendar: https://lician.com/earnings
The latest cached TVRD filing is 8-K · Aug 14, 2026. Filings: https://lician.com/sec/tvrd